Evidence map›Paper›PMID 32580371›Full record

ArticleVaccines2020

Limited Cross-Protection against Infectious Bronchitis Provided by Recombinant Infectious Bronchitis Viruses Expressing Heterologous Spike Glycoproteins.

Sarah Keep, Samantha Sives, Phoebe Stevenson-Leggett, Paul Britton, Lonneke Vervelde, Erica Bickerton

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sarah KeepThe Pirbright Institute, Pirbright, Surrey GU24 0NF, UK.
Samantha SivesDivision of Infection and Immunity, The Roslin Institute and Royal (Dick), School of Veterinary Studies, University of Edinburgh, Easter Bush EH25 9RG, UK.ORCID 0000-0001-9234-1125
Phoebe Stevenson-LeggettThe Pirbright Institute, Pirbright, Surrey GU24 0NF, UK.
Paul BrittonThe Pirbright Institute, Pirbright, Surrey GU24 0NF, UK.
Lonneke VerveldeDivision of Infection and Immunity, The Roslin Institute and Royal (Dick), School of Veterinary Studies, University of Edinburgh, Easter Bush EH25 9RG, UK.ORCID 0000-0003-2241-1743
Erica BickertonThe Pirbright Institute, Pirbright, Surrey GU24 0NF, UK.ORCID 0000-0002-4012-1283
The Pirbright Institute · GBRoslin Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M012069/1Biotechnology and Biological Sciences Research Council BB/M012794/1Biotechnology and Biological Sciences Research Council BBS/E/D/20002174Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007038
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

coronaviruscross-protectionheterologous challengeinfectious bronchitis virusrecombinant vaccinereverse geneticsspike glycoprotein

Identifiers

PMID32580371
PMCPMC7350270
OpenAlexW3036047581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.